These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9659356)

  • 1. Gene therapy for cystic fibrosis: which postman, which box?
    Middleton PG; Alton EW
    Thorax; 1998 Mar; 53(3):197-9. PubMed ID: 9659356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for cystic fibrosis by means of aerosol.
    Rochat T; Morris MA
    J Aerosol Med; 2002; 15(2):229-35. PubMed ID: 12184873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Porteous DJ; Dorin JR; McLachlan G; Davidson-Smith H; Davidson H; Stevenson BJ; Carothers AD; Wallace WA; Moralee S; Hoenes C; Kallmeyer G; Michaelis U; Naujoks K; Ho LP; Samways JM; Imrie M; Greening AP; Innes JA
    Gene Ther; 1997 Mar; 4(3):210-8. PubMed ID: 9135734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for cystic fibrosis.
    Davies JC; Geddes DM; Alton EW
    J Gene Med; 2001; 3(5):409-17. PubMed ID: 11601754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on gene therapy for cystic fibrosis airway disease.
    Bigger B; Coutelle C
    BioDrugs; 2001; 15(9):615-34. PubMed ID: 11580305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy progress and prospects: cystic fibrosis.
    Griesenbach U; Ferrari S; Geddes DM; Alton EW
    Gene Ther; 2002 Oct; 9(20):1344-50. PubMed ID: 12364999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of CF gene therapy.
    Boucher RC
    Trends Genet; 1996 Mar; 12(3):81-4. PubMed ID: 8868343
    [No Abstract]   [Full Text] [Related]  

  • 11. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
    Hyde SC; Southern KW; Gileadi U; Fitzjohn EM; Mofford KA; Waddell BE; Gooi HC; Goddard CA; Hannavy K; Smyth SE; Egan JJ; Sorgi FL; Huang L; Cuthbert AW; Evans MJ; Colledge WH; Higgins CF; Webb AK; Gill DR
    Gene Ther; 2000 Jul; 7(13):1156-65. PubMed ID: 10918483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee T; Southern KW
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis gene therapy.
    Colledge WH
    Curr Opin Genet Dev; 1994 Jun; 4(3):466-71. PubMed ID: 7522673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus for cystic fibrosis gene therapy.
    Martini SV; Rocco PR; Morales MM
    Braz J Med Biol Res; 2011 Nov; 44(11):1097-104. PubMed ID: 21952739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
    Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
    N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy: the case for cystic fibrosis.
    Alton EW; Geddes D
    J R Soc Med; 1997; 90 Suppl 31(Suppl 31):43-6. PubMed ID: 9204011
    [No Abstract]   [Full Text] [Related]  

  • 18. Detergent-lentiviral combination gives gene therapy hope for cystic fibrosis.
    Bradbury J
    Lancet; 2002 Oct; 360(9342):1306. PubMed ID: 12414210
    [No Abstract]   [Full Text] [Related]  

  • 19. Retroviral approaches to gene therapy of cystic fibrosis.
    Johnson LG
    Ann N Y Acad Sci; 2001 Dec; 953():43-52. PubMed ID: 11795422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for cystic fibrosis: current issues.
    Southern KW
    Br J Hosp Med; 1996 Apr 17-30; 55(8):495-9. PubMed ID: 8732222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.